Implantation of primary cultured adipocytes that secrete insulin modifies blood glucose levels in diabetic mice

Diabetologia

Volumn 48, Issue 8, 2005, Pages 1614-1620

  Ito, M ^a   Bujo, H ^a   Takahashi, K ^a   Arai, T ^b   Tanaka, I ^b   Saito, Y ^a  

^a CHIBA UNIVERSITY   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

Adipocytes; Furin; Glycaemic control; Implantation; Insulin

Indexed keywords

COMPLEMENTARY DNA; FURIN; GLYCOGEN; HEMOGLOBIN A1C; INSULIN; PROINSULIN; PROTEIN C; RETROVIRUS VECTOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CULTURE; CELL TRANSFER; CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GENETIC ENGINEERING; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HEMOGLOBIN DETERMINATION; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; STREPTOZOCIN DIABETES; WEIGHT REDUCTION;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; INSULIN; LIVER GLYCOGEN; MALE; MICE; MICE, INBRED C57BL; PANCREAS; RETROVIRIDAE; TISSUE ENGINEERING; WEIGHT LOSS;

EID: 23844556865     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1825-0     Document Type: Article

References (26)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
3. The Diabetes Control and Complications Trial Research Group (1997) Hypoglycemia in the diabetes control and complications trial. Diabetes 46:271-286
4. Barnett AH (2003) A review of basal insulins. Diabet Med 20:873-885
5. Bailey CJ, Davies EL, Docherty K (1999) Prospects for insulin delivery by ex-vivo somatic cell gene therapy. J Mol Med 77:244-249
6. Shimomura I, Funahashi T, Takahashi M et al (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803
7. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432
8. Yamauchi T, Kamon J, Waki H et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
9. Shibasaki M, Takahashi K, Itou T et al (2002) Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha? Diabetologia 45:518-526
10. Sugihara H, Yonemitsu N, Miyabara S, Yun K (1986) Primary cultures of unilocular fat cells: characteristics of growth in vitro and changes in differentiation properties. Differentiation 31:42-49
11. Groskreutz DJ, Sliwkowski MX, Gorman CM (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 269:6241-6245
12. Arai T, Takada M, Ui M, Iba H (1999) Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Virology 260:109-115
13. Muzzin P, Eisensmith RC, Copeland KC, Woo SL (1997) Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol Endocrinol 11:833-837
14. Dong H, Morral N, McEvoy R, Meseck M, Thung SN, Woo SL (2001) Hepatic insulin expression improves glycemic control in type 1 diabetic rats. Diabetes Res Clin Pract 52:153-163
15. Vogt PA (1989) Abdominal lipoplasty technique. Clin Plast Surg 16:279-288
16. Markey AC (2001) Liposuction in cosmetic dermatology. Clin Exp Dermatol 26:3-5
17. Zhang HH, Kumar S, Barnett AH, Eggo MC (2000) Ceiling culture of mature human adipocytes: use in studies of adipocyte functions. J Endocrinol 164:119-128
18. Madsbad S, Alberti KG, Binder C et al (1979) Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. Br Med J 2:1257-1259
19. Johansson BL, Kernell A, Sjoberg S, Wahren J (1993) Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77:976-981
20. Ido Y, Vindigni A, Chang K et al (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277:563-566
21. Sjoquist M, Huang W, Johansson BL (1998) Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54:758-764
22. Pieber TR, Eugene-Jolchine I, Derobert E (2000) Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European study group of HOE 901 in type 1 diabetes. Diabetes Care 23:157-162
23. Rosenstock J, Schwartz SL, Clark CM Jr, Park GD, Donley DW, Edwards MB (2001) Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 24:631-636
24. Kawakami Y, Yamaoka T, Hirochika R, Yamashita K, Itakura M, Nakauchi H (1992) Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes 41:956-961
25. Falqui L, Martinenghi S, Severini GM et al (1999) Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin. Hum Gene Ther 10:1753-1762
26. Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419